When does Respiratory Syncytial Virus (RSV) infection typically peak?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

RSV Infection Peak Timing

RSV infections in the United States typically peak in January or February during the winter season. 1

Seasonal Pattern in the United States

The RSV season follows a predictable pattern across most of the continental United States:

  • Season onset usually begins in November or December 2, 1
  • Peak activity occurs in January or February 2, 1, 3
  • Season conclusion typically ends by late March or sometime in April 2, 1
  • The median season duration is 15 weeks nationally, with regional variation ranging from 13 to 23 weeks 1

Geographic Variation Within the United States

The timing of RSV peaks varies by geographic region due to a clear north-to-south gradient:

  • Southern United States experiences the earliest onset of RSV activity 1
  • Midwestern states tend to experience the latest onset, with median onset at week 1 of the following year 1, 4
  • Western and Northeast regions have seasonal timing that falls between the South and Midwest patterns 1
  • Florida shows substantial variation and requires separate consideration, with an earlier season onset and longer duration than the rest of the country 1, 5, 6

International Patterns

  • In Portugal and Europe, the RSV season typically starts in December, with peak activity occurring during a median epidemic duration of 10 to 11 weeks, though it can extend from October/November to April/May 2
  • In the Northern Hemisphere broadly, RSV circulates predominantly between November and March 1

Clinical Implications for Prophylaxis Timing

Understanding peak timing is critical for optimal prevention strategies:

  • The first dose of palivizumab should be administered before the RSV season starts, typically in November, to provide protection when exposure risk is highest 1, 7
  • Monthly dosing of palivizumab provides more than 20 weeks of protective antibody concentrations, covering most seasonal variation 1
  • Prophylaxis provides the greatest benefit during peak season (January-February), not during periods of low RSV incidence 1

Important Caveats

  • Year-to-year variation occurs within the same community and between communities in the same region, even though the overall pattern remains predictable 1, 4
  • The COVID-19 pandemic disrupted RSV seasonality during 2020-2022, with the 2021-22 season beginning in May and peaking in July, though patterns are returning toward prepandemic timing 3
  • Clinicians should maintain awareness that off-season RSV circulation might continue despite the return toward typical seasonal patterns 3

References

Guideline

RSV Infection Seasonality

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Seasonality of Respiratory Syncytial Virus - United States, 2017-2023.

MMWR. Morbidity and mortality weekly report, 2023

Research

Respiratory syncytial virus--United States, July 2012-June 2014.

MMWR. Morbidity and mortality weekly report, 2014

Research

Respiratory syncytial virus--United States, July 2007-June 2011.

MMWR. Morbidity and mortality weekly report, 2011

Guideline

Palivizumab Prophylaxis for RSV Prevention in High-Risk Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.